(Q43678513)

English

Initiation of insulin glargine in patients with Type 2 diabetes in suboptimal glycaemic control positively impacts health-related quality of life. A prospective cohort study in primary care

scientific article published in September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Initiation of insulin glargine in patients with Type 2 diabetes in suboptimal glycaemic control positively impacts health-related quality of life. A prospective cohort study in primary care (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

quality of life

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

insulin glargine

1 reference

based on heuristic

inferred from title

7

object named as

F J Snoek

0 references

2

object named as

F Pouwer

0 references

author name string

T R S Hajos

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

F Pouwer

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

R de Grooth

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

F Holleman

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

J W R Twisk

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

M Diamant

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

F J Snoek

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Diabetic Medicine

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1096-1102

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03329.X

21 January 2018

Barriers to insulin initiation and intensification and how to overcome them

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03329.X

21 January 2018

Insulin therapy and quality of life. A review.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03329.X

21 January 2018

Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03329.X

21 January 2018

Insulin analogs: impact on treatment success, satisfaction, quality of life, and adherence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03329.X

21 January 2018

Improving treatment satisfaction and other patient-reported outcomes in people with type 2 diabetes: the role of once-daily insulin glargine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03329.X

21 January 2018

A 24-week, randomized, treat-to-target trial comparing initiation of insulin glargine once-daily with insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03329.X

21 January 2018

Fear of hypoglycemia: quantification, validation, and utilization

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03329.X

21 January 2018

Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 Mental Health subscale and the WHO-Five Well-Being Scale.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03329.X

21 January 2018

Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03329.X

21 January 2018

Development and validation of the insulin treatment appraisal scale (ITAS) in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03329.X

21 January 2018

Missing data: our view of the state of the art

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03329.X

21 January 2018

Intensive glycemic control in the ACCORD and ADVANCE trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03329.X

21 January 2018

Hypoglycaemia in Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03329.X

21 January 2018

Well-being and symptoms in relation to insulin therapy in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03329.X

21 January 2018

Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03329.X

21 January 2018

Adding insulin glargine versus rosiglitazone: health-related quality-of-life impact in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03329.X

21 January 2018

Improved glycaemic control in type 1 diabetes patients following participation per se in a clinical trial--mechanisms and implications.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03329.X

21 January 2018

The long-term efficacy of insulin glargine plus oral antidiabetic agents in a 32-month observational study of everyday clinical practice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03329.X

21 January 2018

Insulin initiation in primary care for patients with type 2 diabetes: 3-year follow-up study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03329.X

21 January 2018

Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03329.X

21 January 2018

Symptoms and well-being in relation to glycemic control in type II diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2011.03329.X

21 January 2018

Identifiers

10.1111/J.1464-5491.2011.03329.X

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43678513&oldid=2102443841"